Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO Italy 2020 | Evolving landscape of CAR T-cell therapies

Josep-Maria Ribera • 18 Sep 2020
SOHO Italy 2020
General CAR-T

Josep-Maria Ribera, MD, PhD, Catalan Institute of Oncology, Barcelona, Spain, discusses the evolving field of CAR T-cell therapy in hematological oncology, as well as areas of improvement including durability, novel targets, and the development of new CAR-T constructs. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Josep-Maria Ribera

1:25
BURKIMAB14: dose reduction of chemotherapy in young adults with Burkitt lymphoma
Josep-Maria Ribera • 9 Jun 2023
0:55
PhALLCON: Phase III study of ponatinib vs imatinib in newly diagnosed Ph+ ALL
Josep-Maria Ribera • 9 Jun 2023
1:02
Incorporating immunotherapy into the first-line treatment of ALL
Josep-Maria Ribera • 9 Jun 2023
1:31
PETHEMA LAL19: continuation therapy or allogeneic transplantation according to MRD & genetics in ALL
Josep-Maria Ribera • 8 Oct 2022

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals